ATE335466T1 - Zubereitung zur verabreichung von dithranol - Google Patents

Zubereitung zur verabreichung von dithranol

Info

Publication number
ATE335466T1
ATE335466T1 AT03253186T AT03253186T ATE335466T1 AT E335466 T1 ATE335466 T1 AT E335466T1 AT 03253186 T AT03253186 T AT 03253186T AT 03253186 T AT03253186 T AT 03253186T AT E335466 T1 ATE335466 T1 AT E335466T1
Authority
AT
Austria
Prior art keywords
dithranol
administration
preparation
noisome
dermatophytoses
Prior art date
Application number
AT03253186T
Other languages
German (de)
English (en)
Inventor
Suresh Kumar Gidwani
Purushottam Sharshi Singnurkar
Dahigaon Taluka Post
Original Assignee
Usv Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Usv Ltd filed Critical Usv Ltd
Application granted granted Critical
Publication of ATE335466T1 publication Critical patent/ATE335466T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/21—Emulsions characterized by droplet sizes below 1 micron
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Nanotechnology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03253186T 2002-05-23 2003-05-21 Zubereitung zur verabreichung von dithranol ATE335466T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38299702P 2002-05-23 2002-05-23
US10/371,295 US20030219465A1 (en) 2002-05-23 2003-02-21 Composition for delivery of dithranol

Publications (1)

Publication Number Publication Date
ATE335466T1 true ATE335466T1 (de) 2006-09-15

Family

ID=29406719

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03253186T ATE335466T1 (de) 2002-05-23 2003-05-21 Zubereitung zur verabreichung von dithranol

Country Status (8)

Country Link
US (1) US20030219465A1 (https=)
EP (1) EP1364642B1 (https=)
JP (1) JP2003342171A (https=)
AT (1) ATE335466T1 (https=)
DE (1) DE60307358T2 (https=)
DK (1) DK1364642T3 (https=)
ES (1) ES2269920T3 (https=)
PT (1) PT1364642E (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004274000B2 (en) * 2003-09-19 2009-07-30 Drugtech Corporation Pharmaceutical delivery system
RU2385711C2 (ru) * 2005-03-21 2010-04-10 Лайфкэр Инновейшнз Пвт. Лтд. Многослойная везикулярная композиция
CN101374501A (zh) * 2006-01-05 2009-02-25 药物技术公司 组合物及其使用方法
ATE554743T1 (de) * 2007-09-19 2012-05-15 Bubbles & Beyond Gmbh Reinigungsmittel zur entfernung von farbschichten von oberflächen, verfahren zur herstellung des mittels und verfahren zur reinigung
US9789123B2 (en) 2010-10-21 2017-10-17 Cadila Healthcare Limited Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis
MX2013004296A (es) * 2010-10-21 2013-09-26 Cadila Healthcare Ltd Composiciones farmaceuticas topicas que contienen gotas de tamaño nanometrico para el tratamiento de soriasis.
US8389431B2 (en) * 2011-02-03 2013-03-05 Steag Energy Services Gmbh Method for treating SCR catalysts having accumulated iron compounds
CN103860387B (zh) * 2014-03-06 2016-01-20 东南大学 水杨酸纳米结构脂质载体及其制备方法和应用
US11191704B2 (en) 2014-08-20 2021-12-07 Amantin Experts Compositions and methods for controlled moisturizing and release of active ingredients

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819657A (en) * 1972-10-20 1974-06-25 Gen Mills Chem Inc Methylation of tocopherols
US4102995A (en) * 1976-05-13 1978-07-25 Westwood Pharmaceuticals Inc. Tar gel formulation
US4287214A (en) * 1979-09-24 1981-09-01 Scott Eugene J Van Dithranol compositions stabilized with alpha hydroxyacids
US4367224A (en) * 1981-05-13 1983-01-04 Scott Eugene J Van Stable dithranol compositions in anhydrous vehicles
US4551480A (en) * 1983-06-21 1985-11-05 Stiefel Laboratories, Inc. Compositions for the treatment of psoriasis
DE3603859A1 (de) * 1986-02-07 1987-08-13 Roehm Pharma Gmbh Abwaschbare topische zubereitung zur therapie der psoriasis
US4911928A (en) * 1987-03-13 1990-03-27 Micro-Pak, Inc. Paucilamellar lipid vesicles
IL95393A0 (en) * 1989-08-18 1991-06-30 John Morris Co Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing
DE3936328A1 (de) * 1989-10-27 1991-05-02 Schering Ag Pharmazeutische praeparate
JPH06183953A (ja) * 1991-06-24 1994-07-05 Nippon Oil & Fats Co Ltd 混合脂質膜小胞
US5260065A (en) * 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
US5439967A (en) * 1991-09-17 1995-08-08 Micro Vesicular Systems, Inc. Propylene glycol stearate vesicles
FR2681247B1 (fr) * 1991-09-17 1993-12-03 Oreal Composition pharmaceutique pour application topique contenant du dithranol et procede de preparation.
ATE179883T1 (de) * 1993-07-03 1999-05-15 Procter & Gamble Persönliches reinigungsmittel
FR2716110B1 (fr) * 1994-02-16 1996-04-05 Roussel Uclaf Compositions cosmétiques ou pharmaceutiques comprenant des liposomes.
US5476664A (en) * 1994-04-15 1995-12-19 Leonard Bloom Treatment of warts using anthralins and occlusion
DE19519273A1 (de) * 1995-05-22 1996-11-28 Schering Ag Topisch applizierbare Mittel zur Behandlung und Prophylaxe der Alopezie
GB9514878D0 (en) * 1995-07-20 1995-09-20 Danbiosyst Uk Vitamin E as a solubilizer for drugs contained in lipid vehicles
US6068847A (en) * 1996-10-03 2000-05-30 Johnson & Johnson Consumer Products, Inc. Cosmetic compositions
FR2755856B1 (fr) * 1996-11-21 1999-01-29 Merck Clevenot Laboratoires Microcapsules de chitine ou de derives de chitine contenant une substance hydrophobe, notamment un filtre solaire et procede de preparation de telles microcapsules
JPH10265383A (ja) * 1997-03-25 1998-10-06 Takaaki Akaike 医薬組成物
ATE372377T1 (de) * 1998-03-30 2007-09-15 Mibelle Ag Cosmetics Verwendung von nanoemulsionen zur bestimmung der biokompatibilität von lipophilen stoffen im zellkultur-test und dafür geeignete nanoemulsionen
DE19852928C1 (de) * 1998-11-17 2000-08-03 Steffen Panzner Strukturen in Form von Hohlkugeln
WO2000042990A1 (en) * 1999-01-25 2000-07-27 Optime Therapeutics, Inc. Liposome formulations
JP2000229815A (ja) * 1999-02-05 2000-08-22 Toshimitsu Hattori リポソームおよびその利用
HK1044704A1 (zh) * 1999-03-31 2002-11-01 Abbott Laboratories 含有脂调节剂的新配方
JP5616565B2 (ja) * 1999-05-27 2014-10-29 ユーロ−セルティック エス． ア． 抗炎症剤を適用するための製剤
DE10012151A1 (de) * 2000-03-13 2001-09-27 Gsf Forschungszentrum Umwelt Mittel zur Behandlung von Erkrankungen des Tracheo-Brochialtraktes, insbesondere der COPD

Also Published As

Publication number Publication date
JP2003342171A (ja) 2003-12-03
PT1364642E (pt) 2006-11-30
DE60307358D1 (de) 2006-09-21
DE60307358T2 (de) 2007-08-16
EP1364642B1 (en) 2006-08-09
EP1364642A1 (en) 2003-11-26
ES2269920T3 (es) 2007-04-01
US20030219465A1 (en) 2003-11-27
DK1364642T3 (da) 2006-11-27

Similar Documents

Publication Publication Date Title
DE3780226D1 (de) Neue pharmazeutische praeparate zur topischen applikation, verfahren zu ihrer herstellung und ihre verwendung.
DE69811371D1 (de) Verwendung von substanzen mit oxytocinwirkung zur herstellung von arzneimitteln zur wundheilung
TR200000576T1 (tr) Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem
CR6938A (es) Monohidrato cristalino metodo para su fabricacion y su empleo en la fabricacion de un medicamento.
DK0892638T3 (da) Liposombaseret, topisk vitamin D-præparat
DE69518729D1 (de) Stickstoffoxyd abgebendes präparat zur behandlung von analen erkrankungen
IT1199967B (it) Liposomi contenenti interleucina,metodo per la loro preparazione e loro uso terapeutico nelle affezioni tumorali
ATE216220T1 (de) Osmotische darreichungsform mit zwei mantelschichten
IE870236L (en) Method for stimulation of melanin production
DK1797053T3 (da) Phenothiazinium-forbindelse til sårheling
ATE335466T1 (de) Zubereitung zur verabreichung von dithranol
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
ATE86488T1 (de) Verwendung von minoxidil zur wundheilung.
TR200001486T2 (tr) Hiperkeratozlu deri hastalıklarının tedavisi için diol ve alfa-hidroksi asitten oluşan bir karışımın kullanılması
DE69718169D1 (de) Test zur diagnose von schizophrenie mittels niacin
DE3884309D1 (de) Transdermales Abgabesystem für Procaterol.
ATE33253T1 (de) Verfahren zur herstellung von reinen dermatansulfat- und herapansulfatglykosaminoglukanen und ihre pharmazeutische verwendung.
DE3680227D1 (de) N-cyklohexyl-polycarboxamide verbindung und ihre derivate, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von acceptor-donor-komplexen.
FI964582A7 (fi) Aminosulfonihappojohdannaisia, niiden käyttö pseudopeptidisynteesissä ja menetelmä niiden valmistamiseksi
ATE238987T1 (de) Neue vitamin d-derivate mit cyclopropylringen in den seitenketten, verfahren und zwischenprodukte zu ihrer herstellung sowie ihre verwendung zur herstellung von arzneimitteln
Gehring et al. Enhancement of the penetration of dithranol and increase of effect of dithranol on the skin by liposomes
ATE372763T1 (de) Verwendung von ascorbinsäure zur verstärkung der dermo-epidermischen bindung
FI861345A7 (fi) Efomysiinien käyttö tuotannon edistämiseksi eläimillä, efomysiinejä ja niiden valmistus.
DE3866001D1 (de) Kosmetische und pharmazeutische zusammensetzungen zur topischen anwendung, enthaltend eine c 7 bis c 13 dicarbonsaeure, ein loesliches zinksalz und vitamin b6.
DE69637416D1 (de) Topische anwendung von opioiden, wie morphin, zur linderung von juckreiz und hautkrankheiten sowie hautreizungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1364642

Country of ref document: EP

REN Ceased due to non-payment of the annual fee